DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Nedaplatin is an investigational drug.
There have been 40 clinical trials for Nedaplatin. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2013.
The most common disease conditions in clinical trials are Carcinoma, Nasopharyngeal Neoplasms, and Esophageal Neoplasms. The leading clinical trial sponsors are Sun Yat-sen University, Chinese Academy of Medical Sciences, and Daping Hospital and the Research Institute of Surgery of the Third Military Medical University.
There are two US patents protecting this investigational drug and two international patents.
Recent Clinical Trials for Nedaplatin
|Split-course Thoracic Radiotherapy Combined With Nab-paclitaxel Plus Nedaplatin for Local Advanced NSCLC With Impaired Baseline Pulmonary Function||Sun Yat-sen University||Phase 2|
|Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma||Sun Yat-sen University||N/A|
|Single-arm, Open-label, Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma||Jiangsu HengRui Medicine Co., Ltd.||Phase 2|
Top disease conditions for Nedaplatin
Top clinical trial sponsors for Nedaplatin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Nedaplatin||Start Trial||Estrogen-linked platinum (II) complexes as anticancer agents||Berube; Gervais (Trois-Riviere, CA)||Start Trial|
|Nedaplatin||Start Trial||Macromolecular platinum chelates||Access Pharmaceuticals, Inc. (Dallas, TX)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Nedaplatin||World Intellectual Property Organization (WIPO)||2005002508||2023-06-11||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|